Join the Methotrexate group to help and get support from people like you.
Methotrexate News
Methotrexate Reduces Pain in Hand Osteoarthritis With Synovitis
MONDAY, Nov. 6, 2023 – For patients with hand osteoarthritis and synovitis, methotrexate has a potentially clinically meaningful effect on reducing pain, with no increase in adverse events,...
Both Ciclosporin, Methotrexate Effective for Severe Eczema in Children
TUESDAY, Sept. 26, 2023 – For children and young people with severe atopic dermatitis (AD), ciclosporin (CyA) and methotrexate (MTX) are both effective over 36 weeks, according to a study published...
Dexamethasone Best for Persistent, Recurrent Uveitic Macular Edema
THURSDAY, June 22, 2023 – For patients with minimally active or inactive uveitis and persistent or recurrent uveitic macular edema (ME), dexamethasone is significantly better for treatment than...
FDA Approves RediTrex (methotrexate) for Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Psoriasis
NASHVILLE, Tenn., Dec. 2, 2019 /PRNewswire/ – Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today announced that it has received approval from the U.S. Food and...
FDA Approves Xatmep (methotrexate) Oral Solution
Denver, April 26, 2017 — Silvergate Pharmaceuticals, Inc. leaders in the development and commercialization of innovative and safe medicines for children, today announced that the United States Food a...
FDA Medwatch Alert: Injectable Products by Mylan: Recall - Presence of Particulate Matter
including certain lots of: Gemcitabine for Injection Carboplatin Injection Methotrexate Injection Cytarabine Injection See the press release for a listing of the product strength, NDC, and lot...
FDA Approves Rasuvo (methotrexate) Injection
Chicago, IL, July 14, 2014 – Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced...
Otrexup (Methotrexate) Injection Approved By FDA
EWING, N.J., October 14, 2013 — Antares Pharma, Inc. today announced the approval of Otrexup (methotrexate) injection by the U.S. Food and Drug Administration (FDA). Otrexup is the first FDA approved ...
FDA Medwatch Alert: Methotrexate Sodium, USP Injectable Vials by Sandoz US: Recall - Particulate Matter In Vials
ISSUE: Sandoz is conducting a voluntary nationwide recall to the hospital/user level of two lots of its Methotrexate Sodium, USP, 25 mg/mL, 40 mL vial injectable product in the US, due to the...
FDA Medwatch Alert: Hospira Injectable Drug Products: Recall - Visible Particulates from Defective Glass Vials
Including certain lots of the following products: carboplatin cytarabine paclitaxel methotrexate [Posted 07/16/2012] ISSUE: Hospira and FDA notified healthcare professional of a nationwide recall...
FDA Approves Voraxaze to Treat Patients with Toxic Methotrexate Levels
January 17, 2012 – The U.S. Food and Drug Administration today approved Voraxaze (glucarpidase) to treat patients with toxic levels of methotrexate in their blood due to kidney failure. ...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Acute Lymphoblastic Leukemia, Breast Cancer, Ovarian Cancer, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, Non-Hodgkin's Lymphoma, Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Colorectal Cancer, Eczema, Gastric Cancer, Lymphoma